Table 4 Subgroup characterization.
Composite Biomarkers | Significant clinical variables | |||||||
|---|---|---|---|---|---|---|---|---|
Subgroup | Damage | Integrity | Age | WML | L IPH | MoCA | CVD Risk | Future stroke |
1 | ↓ | -- | ↓ | ↓ | -- | -- | MED | 23.3% |
2 | -- | ↓ | ↑ | ↑ | -- | ↑ | MED | 13.3% |
3 | ↑ | -- | ↑ | ↑ | -- | -- | HIGH | 26.7% |
4 | ↑↑ | ↓↓ | ↑↑ | ↑↑ | ↓ | ↓↓ | LOW | 13.3% |
5 | ↓ | ↑ | ↓ | ↓ | -- | ↑ | MED | 23.3% |
